Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Decide which crypto to buy first between BTC and ETH by weighing use cases, track record, and risk to shape your initial allocation.
25,133 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Warner Bros. Discovery and Paramount Global are exploring a merger that would fold HBO Max and Paramount+ into one pl...
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...
Leveraged ETFs can move markets fast, but that speed cuts both ways. This guide explains how they work, the risks of ...
A once-dismissed Google-backed AI fund has closed a $220 million fifth fund, illustrating how the seeds of AI investi...
The AI hype cycle has investors chasing the next breakout. This article identifies a stock I would avoid and a choice...
This in-depth guide helps investors decode McDonald's 2026 earnings by examining the Q1 transcript, key drivers, and ...
Life360 delivered a strong quarter, but user growth hiccups and a lofty valuation rattled investors. This piece break...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
As Hovnanian prepares to report Q2 2026 earnings, investors will scrutinize backlog, margins, and guidance. This anal...
Nuclear energy has moved from niche to core in many energy plans. This guide breaks down the best nuclear energy stoc...
Midweek market noise can overwhelm your plan. This Wednesday Reads guide distills 10 essential investing topics into ...